Protalix BioTherapeutics Reports Fiscal Year 2021 Financial and Business Results
/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and...
Source: prnewswire.com